Skip to main content
logo
CBD Life Sciences Inc. (CBDL)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0001 (-33.33%)
Jul 27, 2026, 10:08 AM EST

CBD Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.10.10.10.170.160.08
Revenue Growth
-32.20%1.05%-41.79%4.31%92.17%-63.09%
Gross Profit
0.040.040.040.080.090.03
Operating Income
-0.1-0.1-0.76-0.08-0.86-6.14
Net Income
-0.05-0.05-0.76-0.08-0.86-6.14
Earnings Per Share
-0.00-0.00-0.00-0.00-0.01-0.08
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.330.330.01001.03
Total Debt
------
Net Cash (Debt)
0.330.330.01001.03
Net Cash Growth
59326.17%4963.34%160.29%350.90%-99.95%25862.97%
Net Cash Per Share
0.000.000.000.00-0.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.14-0.140.02-0.02-0.8-6.29
Capital Expenditures
-----0.07-0.15
Free Cash Flow
-0.14-0.140.02-0.02-0.87-6.44
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
42.20%42.20%42.21%47.70%53.48%32.90%
Operating Margin
-103.44%-103.44%-782.90%-47.01%-536.57%-7364.79%
Pretax Margin
-49.76%-49.76%-778.18%-47.01%-536.57%-7364.79%
Profit Margin
-49.77%-49.77%-778.18%-47.01%-536.57%-7364.79%
FCF Margin
-141.52%-141.52%15.43%-9.96%-544.92%-7728.80%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--101.05---
PS Ratio
12.0711.5915.600.250.2597.63